Navigation Links
Thomson Reuters Life Sciences Cortellis Competitive Intelligence Reaches Content Milestones
Date:7/24/2013

PHILADELPHIA, July 24, 2013 /PRNewswire/ -- The IP & Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, today announced a series of industry-first milestones in its Cortellis platform. Cortellis, the premier source of life sciences competitive intelligence information and analytics, has reached new content milestones with more than 50,000 investigational drugs, 400,000 bioactive compounds, and six million biologically active patents. In total, the solution contains over 15 million expert, human-curated reports featuring deal information, patents, literature and clinical trials data.

The Cortellis milestones are in addition to new data being integrated into the platform as a result of three recent acquisitions. These include Deloitte Recap, the leading biopharmaceutical provider of life science deals, acquisitions data and analytics; BioWorld and Medical Device Daily, premiere daily news sources in the biopharma and medical device industries; and Timely Data Resources, the esteemed provider of epidemiology information for biopharmaceutical companies, device manufacturers, universities and research institutions. This collective content confirms Cortellis as the industry leading solution for drug discovery, development and commercialization.

"Given the overwhelming amount of public data available, life science professionals need a way to access accurate and relevant information and analytics to support strategic decisions throughout the drug development process," said Jon Brett-Harris, managing director, Thomson Reuters Life Sciences. "Their need underscores the reasoning behind our editorial process and unique Cortellis technology: make the best content findable and actionable for our pharmaceutical cus
'/>"/>

SOURCE Thomson Reuters
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Thomson Reuters Launches New Mobile Oncology Decision Support Solution for R&D Pharmaceutical Leaders
2. Thomson Reuters Finds Increase in New Research for Neglected Tropical Diseases
3. Thomson Reuters Speeds Regulatory Decision Making with New Pharmaceutical Intelligence Solution
4. Thomson Reuters Annual Pharmaceutical Factbook Reveals Key Insights into Current Trends
5. Thomson Reuters Welcomes Inova Software to Its Partner Ecosystem for Life Sciences
6. Roche Selects Thomson Reuters to Transform the Management of Its Intellectual Property Assets
7. Thomson Reuters Empowers Drug Development and Clinical Professionals to Develop Better, Faster Clinical Trials with Best-in-Class Intelligence Solution
8. Thomson Reuters Spotlights the Impact of Personalized Medicine on Pharmaceutical R&D
9. Thomson Reuters Collaborates with One Mind for Research to Advance Traumatic Brain Injury Knowledge
10. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
11. Structural Trends to Profoundly Change Life Sciences Industry, Genpact Study Shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Calif. , Aug. 27, 2015 ... milestone in the commercial development of the company,s ... The Smart Oxygen device, being developed by ieCrowd,s ... to a patient,s changing demand for oxygen based ... the 510 (k) submission for the Smart Oxygen ...
(Date:8/27/2015)... , Aug. 27, 2015  Eli Lilly and Company ... Global Healthcare Conference on Thursday, September 17, 2015. ... of Lilly Oncology and Richard Gaynor , M.D., ... for Lilly Oncology, will participate in a fireside chat ... A live audio webcast will be available on the ...
(Date:8/27/2015)... Aug. 27, 2015   Women Grow , the fastest-growing professional ... partnering with the Cannabis World Congress & Business Exposition ... produce 15 business-focused educational sessions. CWCBExpo in LA will take ... Convention Center in Los Angeles, CA ... West Coast for the marijuana industry. The Women ...
Breaking Medicine Technology:Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 2Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 3Smart Oxygen Solutions' Supplemental Oxygen Delivery Device Achieves FDA Regulatory Pathway Milestone 4Lilly to Participate in Morgan Stanley Global Healthcare Conference 2Cannabis World Congress in Los Angeles Boasts Women Grow Sponsored Education 2Cannabis World Congress in Los Angeles Boasts Women Grow Sponsored Education 3Cannabis World Congress in Los Angeles Boasts Women Grow Sponsored Education 4
... NKTR ) today announced positive results from ... study evaluating single-agent NKTR-102 in women with platinum-resistant/refractory ovarian ... with prior Doxil® (pegylated liposomal doxorubicin or PLD) treatment ... criteria (response by tumor imaging) or Gynecologic Cancer InterGroup ...
... CHICAGO and SAN FRANCISCO, June 4, 2011 ... announced positive results from a Phase 2 clinical ... third-line treatment in patients with metastatic breast cancer ... Meeting (ASCO).  NKTR-102, a next-generation topoisomerase I inhibitor, ...
Cached Medicine Technology:NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil® 2NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil® 3NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil® 4NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil® 5NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil® 6NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil® 7NKTR-102 Shows High Response Rate and Sustained Duration of Response in Women with Platinum-Resistant/Refractory Ovarian Cancer Previously Treated with Doxil® 8NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting 2NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting 3NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting 4NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting 5NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting 6NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting 7NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting 8NKTR-102 Demonstrates Sustained Clinical Benefit in 46% of Patients with Metastatic Breast Cancer in Data Presented at 2011 American Society of Clinical Oncology Annual Meeting 9
(Date:8/30/2015)... Raton, Fl (PRWEB) , ... August 30, 2015 , ... ... to have beneficial effects as sleep aids and calming remedies, which help to improve ... the result of a great deal of research in the field of regenerative medicine ...
(Date:8/29/2015)... ... August 30, 2015 , ... Rio Salado College President Chris Bustamante ... Vice President of Strategic Initiatives and Information Services. O’Shea, who has served Rio Salado ... its reach and impact through innovative technologies and strategies. , “I am very proud ...
(Date:8/29/2015)... ... August 29, 2015 , ... ... support and protection against dribbled urine and sweat. "In order to prevent these ... , The EASY ACCESS DRYNESS ENHANCED MEN'S UNDERGARMENT provides optimal support for a ...
(Date:8/29/2015)... Aliso Viejo, CA (PRWEB) , ... August 29, 2015 , ... ... Cut Pro X . Each preset contains 15 seconds of unique footage that users ... presets that rise, fall, zoom, attract and more. Users can customize color, brightness, scale, ...
(Date:8/28/2015)... (PRWEB) , ... August 29, 2015 , ... Rio ... higher learning and the student experience as part of the EDUCAUSE - Next Generation ... Foundation . , This is the third Breakthrough Models Incubator hosted by ...
Breaking Medicine News(10 mins):Health News:Creative Medical Health’s Natural Rest® Now Available on ReCreative Medical Health’s Natural Rest® Now Available on RevNutrition.com 2Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Modified Men’s Underwear Promote More Comfort and Hygiene - Designed by InventHelp Client (LGI-1968) 2Health News:FCPX Effects Developer, Pixel Film Studios, Releases ProDrop Particles. 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4
... strikes a chord ... with frustrated women, SALT LAKE CITY, March 12 ... undertones., "I love the commercial because sometimes my husband remembers to ... make any,difference," says a customer service rep (who wishes to remain anonymous),at ...
... in U.S. may block brain receptor among some users ... weight-loss drug rimonabant has been associated with troubling psychiatric ... why. , A receptor in the brain called TRPV1, ... blocked by large doses of rimonabant (Acomplia), resulting in ...
... IVF Success, NEWBURGH, N.Y., March 12 ... Mount Sinai Hospital, is proud to introduce,premier fertility ... of,Reproductive Endocrinologist Jeffrey Klein, M.D. to its medical ... Westchester division of,Reproductive Medicine Associates (RMA) of New ...
... Institutets Board of Research confers the title honorary doctor ... have promoted activities carried out at the university. This ... conferred. The ceremony will take place on Friday 9 ... honorary doctors will receive their doctoral hats, diplomas and ...
... that restores a missing liver enzyme in test animals ... in humans, according to Duke University Medical Center researchers. ... disease type Ia (GSD-Ia), cant make an enzyme that ... that all cells use for energy. Without treatment, their ...
... Founders donating stock to establish corporate foundation; Community ... program helps care for the aging in Bay ... Caring.com is pleased to,announce its participation as the ... dedicated to engaging high-growth,companies in corporate citizenship and ...
Cached Medicine News:Health News:An Important Message to Anyone Taking Viagra ... From The Women Who Love You ... and Zoller Labs 2Health News:Possible Reason for Rimonabant's Side Effects Discovered 2Health News:Possible Reason for Rimonabant's Side Effects Discovered 3Health News:SLCH Brings Infertility Specialist to Region 2Health News:3 new honorary doctors at Karolinska Institutet 2Health News:Gene therapy could save kids from a lifetime of eating cornstarch 2Health News:Gene therapy could save kids from a lifetime of eating cornstarch 3Health News:Caring.com Joins Entrepreneurs Foundation as 200th Member 2
200 L, Racked, Filtered, Pre-sterilized, 96 tips/rack Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
... aerosol contamination, which causes ... PCR. Hydrophobic, nonwicking and ... can pass through these ... contrast to tips with ...
Diamond Filter Tips play a critical role in preventing aerosol-borne contamination. Also available sterilized (no need to autoclave) and certified free of detectable RNase, DNase, DNA, RNA, and prote...
... Filters are ideal for PCR ... for any work where aerosol ... designed for pipetting DNA/RNA solutions, ... other. For applications requiring absolute ...
Medicine Products: